Filtered By:
Condition: Pulmonary Hypertension
Procedure: Heart Valve Surgery

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 65 results found since Jan 2013.

Aortic Valve Replacement in the Moderately Elevated Risk Patient: A Population-Based Analysis of Outcomes.
CONCLUSIONS: This population-based contemporary assessment suggests moderate-risk patients undergoing AVR experience favorable outcomes. Although increasing PROM is important in preoperative evaluation of risk, preexisting pulmonary hypertension and indication for operation are among other factors that should be considered as TAVR expands into this group of patients. PMID: 27324524 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - June 17, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Patel HJ, Likosky DS, Pruitt AL, Murphy ET, Theurer PF, Prager RL Tags: Ann Thorac Surg Source Type: research

Systemic Hypertension in Low Gradient Severe Aortic Stenosis with Preserved Ejection Fraction.
CONCLUSIONS: Systemic hypertension in LG severe AS with preserved EF is associated with elevated LV filling pressures and pulmonary hypertension. Treatment of hypertension with vasodilator therapy results in a lowering of the total LV afterload, with a decrease in LV filling pressures and pulmonary artery pressures. These findings have important implications for the management of patients with LG severe AS with preserved EF and hypertension. PMID: 23956211 [PubMed - as supplied by publisher]
Source: Circulation - August 16, 2013 Category: Cardiology Authors: Eleid MF, Nishimura RA, Sorajja P, Borlaug BA Tags: Circulation Source Type: research

138 * transapical aortic valve implantation in patients with and without severe calcification of the ascending aorta: different preoperative characteristics but no difference in outcome
Conclusions: In contrast to conventional aortic valve replacement, severe calcification of the ascending aorta has no negative influence on perioperative outcome and long-term survival after transapical TAVI.
Source: Interactive CardioVascular and Thoracic Surgery - September 18, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Buz, S., Pasic, M., Drews, T., Dreysse, S., Kukucka, M., Mladenow, A., Hetzer, R., Unbehaun, A. Tags: Transcatheter aortic valve implantation: Expanding indications and techniques Source Type: research

Continuous Flow Left Ventricular Assist Device Implant Significantly Improves Pulmonary Hypertension, Right Ventricular Contractility, and Tricuspid Valve Competence
ConclusionContinuous flow LVAD implant improves pulmonary hypertension, RV function, and tricuspid regurgitation. TR may be managed nonoperatively during CF LVAD implant.
Source: Journal of Cardiac Surgery - September 30, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Pavan Atluri, Alexander S. Fairman, John W. MacArthur, Andrew B. Goldstone, Jeffrey E. Cohen, Jessica L. Howard, Christyna M. Zalewski, Yasuhiro Shudo, Y. Joseph Woo Tags: Original Article Source Type: research

Short-Term Results of Transapical Transcatheter Mitral Valve Implantation for Mitral Regurgitation
ConclusionsTransapical transcatheter mitral valve implantation is technically feasible and can be performed safely. Early hemodynamic performance of the prosthesis was excellent. Transcatheter mitral valve implantation may become an important treatment option for patients with severe MR who are at high operative risk.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - October 20, 2014 Category: Cardiology Source Type: research

Long-Term Results of Transapical Versus Transfemoral TAVI in a Real World Population of 1000 Patients With Severe Symptomatic Aortic Stenosis Structural Heart Disease
Conclusions— The data demonstrate that in an experienced multidisciplinary heart team, either access route can be performed with comparable results.
Source: Circulation: Cardiovascular Interventions - December 31, 2014 Category: Cardiology Authors: Schymik, G., Wurth, A., Bramlage, P., Herbinger, T., Heimeshoff, M., Pilz, L., Schymik, J. S., Wondraschek, R., Suselbeck, T., Gerhardus, J., Luik, A., Gonska, B.-D., Posival, H., Schmitt, C., Schrofel, H. Tags: CV surgery: valvular disease Structural Heart Disease Source Type: research

Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation
Conclusions ExPHT is associated with increased risk of adverse cardiac events following mitral valve surgery in patients with primary MR.
Source: Heart - February 12, 2015 Category: Cardiology Authors: Magne, J., Donal, E., Mahjoub, H., Miltner, B., Dulgheru, R., Thebault, C., Pierard, L. A., Pibarot, P., Lancellotti, P. Tags: Drugs: cardiovascular system, Echocardiography, Hypertension, Mitral valve disease, Clinical diagnostic tests Valvular heart disease Source Type: research

Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
Conclusion Rheumatic heart disease patients were young, predominantly female, and had high prevalence of major cardiovascular complications. There is suboptimal utilization of secondary antibiotic prophylaxis, oral anti-coagulation, and contraception, and variations in the use of percutaneous and surgical interventions by country income level.
Source: European Heart Journal - May 7, 2015 Category: Cardiology Authors: Zuhlke, L., Engel, M. E., Karthikeyan, G., Rangarajan, S., Mackie, P., Cupido, B., Mauff, K., Islam, S., Joachim, A., Daniels, R., Francis, V., Ogendo, S., Gitura, B., Mondo, C., Okello, E., Lwabi, P., Al-Kebsi, M. M., Hugo-Hamman, C., Sheta, S. S., Haile Tags: Valvular heart disease Source Type: research

The Challenge of Timing Surgery in Degenerative Mitral Regurgitation Is B-Type Natriuretic Peptide the Solution? ∗
Degenerative mitral regurgitation (MR) with prolapse or flail of mitral leaflets has become the most frequent cause of severe primary MR in Europe and North America (1,2). In its chronic stage, even severe MR is tolerated very well for a surprisingly long time, and patients may remain asymptomatic for years. During this compensated stage of disease, pre-load, afterload, and both contractility and ejection fraction of the left ventricle (LV) remain normal, and the total stroke volume is increased as a result of the compensatory enlargement of the end-diastolic LV volume, which is enabled by an adaptive process of the LV myo...
Source: Journal of the American College of Cardiology - September 13, 2016 Category: Cardiology Source Type: research

Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement.
CONCLUSIONS: PH is a risk factor for worse outcome of SAVR and TAVR, this fact is less pronounced among TAVR patients and our data suggest a shift towards the transcatheter approach in patients suffering PH. PMID: 28437243 [PubMed - as supplied by publisher]
Source: EuroIntervention - April 26, 2017 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Transcatheter Aortic Valve Implantation Versus Re-do Surgery for Failing Surgical Aortic Bioprosthesis: a Multi-Centre Propensity Score Analysis.
CONCLUSIONS: Patients with aortic bioprosthesis failure treated with either redo-SAVR or TAV-in-SAV have similar 30-day and 1-year clinical outcomes. PMID: 28760721 [PubMed - as supplied by publisher]
Source: EuroIntervention - August 3, 2017 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Initial experience with percutaneous edge-to-edge transcatheter mitral valve repair in a tertiary medical center in Taiwan
Conclusion Trans-catheter edge-to-edge mitral valve repairs are safe and effective in Asians with symptomatic SMR, regarding the improvements of clinical symptoms and exercise capacities. MitraClips is also associated with reverse remodeling of pulmonary hypertension and left ventricular size in patients with SMR.
Source: Journal of the Chinese Medical Association - December 29, 2017 Category: General Medicine Source Type: research

Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease
ConclusionsECMO can be used as a bridge to heart valve or septal defect surgery in severely decompensated patients. Through recovery of end-organ function, ECMO may allow surgical correction of structural heart disease in patients considered inoperable or convert a salvage situation to an elective operation.
Source: The Annals of Thoracic Surgery - September 18, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease.
CONCLUSIONS: ECMO can be used as a bridge to heart valve or septal defect surgery in severely decompensated patients. Through recovery of end-organ function, ECMO may allow surgical correction of structural heart disease in patients considered inoperable or convert a salvage situation to an elective operation. PMID: 30236527 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - September 17, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Watkins AC, Maassel NL, Ghoreishi M, Dawood MY, Pham SM, Kon ZN, Taylor BS, Griffith BP, Gammie JS Tags: Ann Thorac Surg Source Type: research

A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
CONCLUSION: In this study, we could not detect an advantage in survival when SAVR or TAVR were utilized in intermediate to high surgical risk patients needing aortic valve replacement for severe aortic stenosis. PMID: 31596707 [PubMed - in process]
Source: The Heart Surgery Forum - August 26, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Abdelgawad AME, Hussein MA, Naeim H, Abuelatta R, Alghamdy S Tags: Heart Surg Forum Source Type: research